CanaQuest has been awarded, Medical Cannabinoid Development Company of the Year 2024 and Endocannabinoid Therapeutics Development Company of the Year 2024 by Global Health & Pharma, UK in its ninth annual Healthcare and Pharmaceutical Awards.
No files for the selected year.